Rishi Paliwal

4.0k total citations · 1 hit paper
63 papers, 2.9k citations indexed

About

Rishi Paliwal is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Rishi Paliwal has authored 63 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Pharmaceutical Science and 20 papers in Biomaterials. Recurrent topics in Rishi Paliwal's work include Nanoparticle-Based Drug Delivery (19 papers), Advanced Drug Delivery Systems (18 papers) and RNA Interference and Gene Delivery (10 papers). Rishi Paliwal is often cited by papers focused on Nanoparticle-Based Drug Delivery (19 papers), Advanced Drug Delivery Systems (18 papers) and RNA Interference and Gene Delivery (10 papers). Rishi Paliwal collaborates with scholars based in India, United States and Germany. Rishi Paliwal's co-authors include Shivani Rai Paliwal, Srinath Palakurthi, Suresh P. Vyas, Balak Das Kurmi, R. Jayachandra Babu, Govind P. Agrawal, Sheetu Wadhwa, Shivani Rai, Bhuvaneshwar Vaidya and Amit K. Goyal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Rishi Paliwal

61 papers receiving 2.8k citations

Hit Papers

Zein in controlled drug delivery and tissue engineering 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rishi Paliwal India 26 992 951 924 626 327 63 2.9k
Eliana Martins Lima Brazil 32 1.2k 1.2× 1.1k 1.2× 1.1k 1.1× 651 1.0× 322 1.0× 128 3.6k
Simin Dadashzadeh Iran 30 944 1.0× 965 1.0× 855 0.9× 466 0.7× 165 0.5× 119 2.8k
Haibing He China 31 997 1.0× 932 1.0× 996 1.1× 610 1.0× 188 0.6× 148 3.2k
Florence Delié Switzerland 29 1.0k 1.1× 1.3k 1.3× 1.2k 1.3× 893 1.4× 215 0.7× 72 3.9k
Juliana Maldonado Marchetti Brazil 33 1.0k 1.0× 966 1.0× 908 1.0× 930 1.5× 257 0.8× 72 3.4k
Naveed Ahmed Pakistan 31 1.0k 1.0× 914 1.0× 657 0.7× 756 1.2× 212 0.6× 146 3.5k
Pedro Fonte Portugal 34 1.3k 1.3× 813 0.9× 1.1k 1.2× 446 0.7× 428 1.3× 67 3.2k
Marina Gallarate Italy 32 1.7k 1.7× 795 0.8× 1.2k 1.3× 456 0.7× 478 1.5× 97 3.5k
Munira Momin India 24 500 0.5× 557 0.6× 924 1.0× 585 0.9× 245 0.7× 85 2.7k
Sepideh Khorasani Iran 8 946 1.0× 908 1.0× 1.0k 1.1× 617 1.0× 624 1.9× 15 3.7k

Countries citing papers authored by Rishi Paliwal

Since Specialization
Citations

This map shows the geographic impact of Rishi Paliwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishi Paliwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishi Paliwal more than expected).

Fields of papers citing papers by Rishi Paliwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishi Paliwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishi Paliwal. The network helps show where Rishi Paliwal may publish in the future.

Co-authorship network of co-authors of Rishi Paliwal

This figure shows the co-authorship network connecting the top 25 collaborators of Rishi Paliwal. A scholar is included among the top collaborators of Rishi Paliwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishi Paliwal. Rishi Paliwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Vaiphei, Klaudi K., et al.. (2024). Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer. Nanomedicine. 19(15). 1347–1368. 6 indexed citations
4.
Kenwat, Rameshroo, et al.. (2024). QbD-based optimization and evaluation of chitosan-adorned nanostructured lipid carriers for nose-to-brain delivery of 17β-Estradiol in rat model of Alzheimer's disease. Journal of Drug Delivery Science and Technology. 96. 105716–105716. 2 indexed citations
5.
Sulakhiya, Kunjbihari, et al.. (2024). Madhuca indica oil-entrapped buoyant galactomannan hydrogel microspheres for controlling epileptic seizures. International Journal of Biological Macromolecules. 272(Pt 1). 132739–132739.
6.
Paul, Swarnali Das, et al.. (2023). Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation. Colloids and Surfaces B Biointerfaces. 223. 113160–113160. 12 indexed citations
7.
Paliwal, Rishi, et al.. (2023). Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India. Current Drug Safety. 19(2). 172–190. 2 indexed citations
8.
Kurmi, Balak Das, Preeti Patel, Rishi Paliwal, Pramod Kumar, & Shivani Rai Paliwal. (2023). Multifunctional Nanotherapeutics for Intracellular Trafficking of Doxorubicin Against Breast Cancer. Nanomedicine. 18(19). 1261–1279. 8 indexed citations
9.
Paliwal, Rishi, et al.. (2023). Lentinan: An unexplored novel biomaterial in drug and gene delivery applications. Journal of Controlled Release. 356. 316–336. 18 indexed citations
10.
Prajapati, Shiv Kumar, Gaurav Mishra, Payal Kesharwani, et al.. (2022). An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations. Journal of Ethnopharmacology. 296. 115420–115420. 19 indexed citations
11.
Paliwal, Rishi, et al.. (2021). Development of Nanomedicines and Nano-Similars: Recent Advances in Regulatory Landscape. Current Pharmaceutical Design. 28(2). 165–177. 10 indexed citations
12.
13.
Paliwal, Shivani Rai, Rameshroo Kenwat, Sabyasachi Maiti, & Rishi Paliwal. (2020). Nanotheranostics for Cancer Therapy and Detection: State of the Art. Current Pharmaceutical Design. 26(42). 5503–5517. 8 indexed citations
14.
Paliwal, Rishi, Shivani Rai Paliwal, Rameshroo Kenwat, Balak Das Kurmi, & Mukesh Sahu. (2020). Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opinion on Therapeutic Patents. 30(3). 179–194. 236 indexed citations
15.
Mishra, Sandhya, et al.. (2019). The Functional Nanogel: An Exalted Carrier System. Journal of Drug Delivery and Therapeutics. 9(2-s). 570–582. 7 indexed citations
16.
Mishra, Neeraj, Amit K. Goyal, Shailja Tiwari, et al.. (2010). Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opinion on Therapeutic Patents. 20(5). 661–679. 45 indexed citations
17.
Wadhwa, Sheetu, Rishi Paliwal, Shivani Rai Paliwal, & Suresh P. Vyas. (2009). Chitosan and its Role in Ocular Therapeutics. Mini-Reviews in Medicinal Chemistry. 9(14). 1639–1647. 53 indexed citations
18.
Wadhwa, Sheetu, Rishi Paliwal, Shivani Rai Paliwal, & Suresh P. Vyas. (2009). Nanocarriers in Ocular Drug Delivery: An Update Review. Current Pharmaceutical Design. 15(23). 2724–2750. 143 indexed citations
19.
Rawat, Amit, Bhuvaneshwar Vaidya, Kusum Khatri, et al.. (2007). Targeted intracellular delivery of therapeutics: an overview.. PubMed. 62(9). 643–58. 17 indexed citations
20.
Paliwal, Rishi, Dharmendra Jain, Ram Gaud, & Piyush Trivedi. (1998). SIMULTANEOUS ESTIMATION OF METRONIDAZOLE AND NALIDIXIC ACID IN TWO COMPONENT PHARMACEUTICAL DOSAGE FORMS BY ULTRAVIOLET SPECTROPHOTOMETRY. Indian Journal of Pharmaceutical Sciences. 60(3). 140–143. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026